References
- Alex R., Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of Microencapsulation 1990; 7: 347–355
- Chitambara Thanoo B., Jayakrishnan A. Tantalum loaded silicone microspheres as particulate emboli. Journal of Microencapsulation 1991; 8: 95–101
- Di Colo G. Controlled drug release from implantable matrices based on hydrophobic polymers. Biomaterials 1992; 13: 850–856
- Etienne A. New opportunities for controlled drug delivery systems based on silicone polymer technology. S. T. P. Pharma 1990; 1: 33–40
- Ghosh T., Gokhale R., Chiao C. In-vitro assessment of a matrix system of levobunolol. Journal of Pharmacy and Pharmacology 1992; 44: 512–514
- Milligan S., Cohen P. Silastic implants for delivering physiological concentrations of progesterone to mice. Reproduction and Fertility Development 1994; 6: 235–239
- Muller D., Gordon D., Topol E., Levy R., Golomb G. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting. American Heart Journal 1996; 131: 211–218
- Sutinen R., Urtti A., Raatikainen P., Paronkn P. Dissolution medium independent release of propranolol from silicone reservoir devices. International Journal of Pharmaceutics 1993; 92: 177–181
- Sutinen R., Laasanen V., Paronen P., Urtti A. pH-controlled silicone microspheres for controlled drug delivery. Journal of Controlled Release 1995; 33: 163–171
- Tien J. Transdermal-controlled administration of oxycodone. Journal of Pharmacetitical Sciences 1991; 80: 741–743
- Urtti A., Rouhiainen H., Kaila T., Saano V. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans. Pharmaceutical Research 1994; 11: 1278–1282